Altre lingue Applied Therapeutics, Inc.

Azioni

APLT

US03828A1016

Biotecnologia

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 12/12/2025			Variaz. 5gg	Var. 1 gen.
0,1173 ^USD	-45,92%		-45,84%	-86,30%

12/12	APPLIED THERAPEUTICS, INC. : RBC Capital Markets Neutral sul caso	ZM
03/12	APPLIED THERAPEUTICS, INC. : Leerink Partners dà una valutazione Neutrale	ZM

Altre lingue

Cycle Group Holdings Limited entered into a definitive agreement to acquire Applied Therapeutics, Inc. for $13.4 million.	12/12
APLT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Applied Therapeutics, Inc. is Fair to Shareholders	12/12
Cycle Pharmaceuticals to Acquire Applied Therapeutics	11/12
Applied Therapeutics Announces Corporate Updates	20/11
Applied Therapeutics Announces Reduction of Workforce by Approximately 46%	20/11
Applied Therapeutics Reports Third Quarter 2025 Financial Results	14/11
Applied Therapeutics, Inc. Announces Resignation of John Johnson as Executive Chairman and as Director in November 2025	13/11
Applied Therapeutics Q3 net loss of $19 mln beats expectations	13/11
Applied Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	13/11
Applied Therapeutics Reports Third Quarter 2025 Financial Results	13/11
Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights	28/10
Applied Therapeutics Shares Slide After FDA Meeting on Govorestat	29/09
Applied Therapeutics Says Path Forward Not Determined for Govorestat; Shares Fall Pre-Bell	29/09
Applied Therapeutics provides update following meeting with FDA	29/09
Applied Therapeutics Provides Update Following Meeting with FDA	29/09
Applied Therapeutics, Inc. Provides Update Following Meeting with FDA	29/09
Applied Therapeutics, Inc.(NasdaqCM:APLT) dropped from S&P Global BMI Index	22/09
Applied Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	13/08
Applied Therapeutics Reports Second Quarter 2025 Financial Results	13/08
Applied Therapeutics says unaudited estimate of total stockholders' equity as of June 30 is about $17.4 mln	12/08
Applied Therapeutics announces key leadership appointments	18/06
Applied Therapeutics Promotes Evan Bailey to Chief Medical Officer	17/06
Applied Therapeutics Announces Key Leadership Appointments	17/06
Applied Therapeutics Announces Leadership Appointments	17/06
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting	18/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Applied Therapeutics, Inc.

Azioni

APLT

US03828A1016

Biotecnologia

Altre lingue

Filtri